McKesson Europe (OTCMKTS:CAKFY) vs. Syra Health (NASDAQ:SYRA) Head to Head Analysis

Valuation & Earnings

This table compares Syra Health and McKesson Europe”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Syra Health $7.98 million 1.56 -$2.94 million $0.01 90.00
McKesson Europe N/A N/A N/A $0.09 47.67

McKesson Europe has lower revenue, but higher earnings than Syra Health. McKesson Europe is trading at a lower price-to-earnings ratio than Syra Health, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

4.8% of Syra Health shares are owned by institutional investors. Comparatively, 0.0% of McKesson Europe shares are owned by institutional investors. 36.5% of Syra Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Profitability

This table compares Syra Health and McKesson Europe’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Syra Health -54.90% -131.94% -99.19%
McKesson Europe N/A N/A N/A

Summary

McKesson Europe beats Syra Health on 5 of the 8 factors compared between the two stocks.

About Syra Health

(Get Free Report)

Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions. The company also engages in developing Syrenity, an on-demand telehealth platform for mental health services. In addition, the company provides healthcare staffing solutions; and digital health solutions comprising digital transformation, cloud and security, artificial intelligence, patient engagement, and health apps. It serves mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. Syra Health Corp. was incorporated in 2020 and is headquartered in Carmel, Indiana.

About McKesson Europe

(Get Free Report)

McKesson Europe AG provides logistics and other services to the pharmaceutical and healthcare sectors worldwide. The company operates through two divisions, Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution division engages in the wholesale of pharmaceutical and other health care products. This division serves its customers through 90 wholesale branches that supply pharmaceutical products to approximately 40,000 pharmacies and hospitals, as well as operates 70 distribution centers in Europe. The Retail Pharmacy division operates approximately 2,000 owned pharmacies and approximately 8,000 members in its brand partnership program. This division also provides outpatient drug, e-commerce, and home care services primarily in Belgium, Ireland, Italy, and the United Kingdom under the Lloyds Pharmacy brand. In addition, this division provides traditional prescription drugs, over-the-counter products, and medical services. It also provides other services for pharmacists, such as the organization and management of pharmacy cooperation programs in the Great Britain, France, Portugal, and Belgium. The company was formerly known as Celesio AG and changed its name to McKesson Europe AG in September 2017. The company was founded in 1835 and is headquartered in Stuttgart, Germany. McKesson Europe AG is a subsidiary of McKesson Corporation.

Receive News & Ratings for Syra Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syra Health and related companies with MarketBeat.com's FREE daily email newsletter.